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advantageous. Recently, plasma membrane calcium ATPase 4
(PMCA) has been established as a novel mediator of angiogen-
esis through its role in endothelial cell migration and tubule
formation. In addition to PMCA4, both PMCA1 and PMCA2
are also expressed in human endothelial cells but their contri-
bution to angiogenesis remains unknown. Therefore, we
hypothesise that PMCA1 also modulates angiogenesis by alter-
ing endothelial cell behaviours.
Transient knockdown of PMCA1 was achieved in human
umbilical vein endothelial cells (HUVECs) using siRNA (si-
PMCA1) and confirmed with qPCR and western blot. Assays
to asses HUVEC viability, proliferation and rate of apoptosis
were performed over a period of 6 days post-transfection
using Alamar Blue, Ki-67 immunofluorescence and Caspase-
Glo 3/7 respectively. In addition, live-cell imaging was per-
formed over a period of 21 hours to further evaluate migra-
tion of cells in a wound, cell necrotic cytotoxicity and cell
apoptotic death. Furthermore, HUVECs were added to Matri-
gel to evaluate in-vitro tubule formation and DAPI-stained
cells were subject to fluorescent activated cell sorting to deter-
mine cell-cycle distribution. Molecular mechanisms were inves-
tigated using Western blot.
Transient knockdown of PMCA1 in HUVECs resulted in
an 85% reduction of PMCA1 at both mRNA and protein
level but did not alter the levels of PMCA4 mRNA up to
6 days post transfection. Phenotypically, 3 and 6 days post-
transfection, loss of PMCA1 significantly reduced HUVEC via-
bility without a concomitant increase in HUVEC apoptosis or
cytotoxicity. Immunofluorescent staining for Ki-67 showed no
statistical difference between si-PMCA1 and control HUVECs
for the percentage of Ki-67 positive cells. However, FACs-
mediated cell cycle analysis revealed si-PMCA1 HUVECs had
a significantly larger proportion of cells in G0/G1 phase with
fewer cells identified in G2/M-phase compared to control
HUVECs after serum starvation followed by 8 hours of full
serum media. Additionally, live-cell imaging of the wound
healing assay revealed si-PMCA1 HUVECs displayed signifi-
cantly reduced HUVEC wound density and wound confluence,
resulting in an increased wound width over time. Further-
more, si-PMCA1 also show reduced ability to form tubules in-
vitro characterised by a reduction in the number of tubules
and tubule junctions formed, despite si-PMCA1 HUVECs hav-
ing higher protein levels of the pro-angiogenic gene
RCAN1.4.
Overall, transient knockdown of PMCA1 has adverse effects
on HUVEC viability, migration and tubule formation suggesting
loss of PMCA1 is detrimental for in-vitro angiogenesis.
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Ageing is the biggest risk factor for impaired cardiovascular
health, cardiovascular disease being the leading cause of death
in 40% of individuals over 65 years old. Ageing is associated
not only with an increased prevalence of cardiovascular dis-
ease but also with a poorer prognosis, including increased
mortality or incidence of heart failure after myocardial infarc-
tion (MI).
We have demonstrated that aged (23 month old) mice have
an accumulation of cardiomyocyte senescence, reduced regen-
erative potential and display increased mortality as well as
impaired recovery following MI. Cellular senescence is defined
not only by the irreversible loss of division potential but also
by the production of a senescence-associated secretory pheno-
type (SASP). This cocktail of pro-inflammatory cytokines, che-
mokines, matrix proteases and growth factors can impact on
tissue function, inducing fibrosis, extracellular matrix degenera-
tion and driving inflammation. We have therefore begun to
test if clearance of senescent cardiomyocytes, using the seno-
lytic compound Navitoclax, has the potential to improve car-
diac health and post MI outcomes in aged animals. Following
treatment with Navitoclax, but prior to MI, aged mice dem-
onstrated a reduction in senescent cardiomyocytes which was
associated increased cardiomyocyte generation, a decline in
myocardial hypertrophy and a decrease in fibrosis. Following
MI, Navitoclax treated mice displayed a tendency towards
improved survival and had a significant improvement in car-
diac function when compared to vehicle controls.
We conclude that clearance of senescent cells is a potential
therapeutic strategy for the treatment of age related cardiac
dysfunction.
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Introduction Coronary artery disease is the leading cause of
death worldwide. Stent implantation is performed widely to
revascularise stenosed coronary arteries. Restenosis is a signifi-
cant complication associated with bare metal stents (BMS).
Drug eluting stents with adjunct anti-platelet therapy signifi-
cantly improved restenosis risk but introduced late in stent
thrombosis. Therefore, there remains a need for more effec-
tive coronary artery stents and the aim of this study is to
improve currently available BMSs. Graphene is a 2D material
consisting of a layer of hexagonal structured carbon atoms,
exhibiting unique properties, ideal for implantable device coat-
ings: it forms an impermeable membrane, is atomically smooth
and has a Daruyhigh surface to volume ratio.
We have coated currently available BMSs with graphene-
based materials to enhance re-endothelialisation and hinder the
formation of intimal hyperplasia resulting from possible aetiol-
ogies such as metal leaching or inflammatory reaction to the
metal itself.
Methods Graphene-based bare metal stent coatings were opti-
mised by investigating several coating methods. Human coro-
nary artery endothelial cells (HCAECs) were cultured on
control and coated stents. Cells were fixed at day 0 and day
8 post-seeding, followed by Hoechst 33 342 and Phalloidin
staining for viewing under the fluorescence microscope. Subse-
quently, HCAEC number per mm2 area of stent was deter-
mined at both day 0 and day 8, and the difference calculated.
One-Way ANOVA with multiple comparison was performed
and p<0.05 considered as statistically significance. Results are
shown as mean± SEM.
Abstracts
A84 Heart 2018;104(Suppl 6):A1–A118
 o
n
 6 August 2018 by guest. Protected by copyright.
http://heart.bmj.com/
H
eart: first published as 10.1136/heartjnl-2018-BCS.105 on 1 June 2018. Downloaded from 
